Micro and Nanocarriers for Biomedicine

A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Drug Delivery".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 2086

Special Issue Editor


E-Mail Website
Guest Editor
Instituto de Nanociencia y Materiales de Aragón (INMA) CSIC, Universidad de Zaragoza, Zaragoza, Spain
Interests: biomaterial; nanocarriers; drug delivery; nanoaerosols; pulmonary delivery; microencapsulation

Special Issue Information

Dear Colleagues,

The goal of this Special Issue is to show a current outlook of functional micro- and nanocarriers for biomedical applications through original research or review articles on this subject.

Nanotechnology is a science involving the manipulation of matter on an atomic and molecular scale, in the size range of a few to several hundred nanomaterials. Their application in the biomedical field provides conventional medicine with new tools for tissue repair, diagnostics and treatment of pathologies, often by delivering drugs to tissues and areas of interest. In this sense, micro and nanocarriers have been widely investigated in recent decades. Nano-based carriers allow for high control of their properties with a high surface area/volume ratio. This allows them to alter the bioactivity of drugs, improving their pharmacokinetics, biodistribution and solubility, decreasing toxicity, preventing drug degradation and allowing controlled drug release of therapeutic agents to specific target sites. In short, they offer a wide range of new treatment opportunities.

We invite both research manuscripts and reviews focusing on a wide range of issues and concerns regarding nano-based carriers for biomedical applications.

Dr. María Pilar Lobera González
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • micro- and nanocarrier
  • biomaterials for drug delivery
  • tissue repair
  • biomaterials for diagnostics
  • antibacterial biomaterials
  • biomaterials for cancer therapies

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1318 KiB  
Review
Cellular Alterations in Carbohydrate and Lipid Metabolism Due to Interactions with Nanomaterials
by Ana Martín-Pardillos and Pilar Martin-Duque
J. Funct. Biomater. 2023, 14(5), 274; https://doi.org/10.3390/jfb14050274 - 14 May 2023
Cited by 3 | Viewed by 1782
Abstract
Nanoparticles (NPs) have unique physicochemical properties that are useful for a broad range of biomedical and industrial applications; nevertheless, increasing concern exists about their biosafety. This review aims to focus on the implications of nanoparticles in cellular metabolism and their outcomes. In particular, [...] Read more.
Nanoparticles (NPs) have unique physicochemical properties that are useful for a broad range of biomedical and industrial applications; nevertheless, increasing concern exists about their biosafety. This review aims to focus on the implications of nanoparticles in cellular metabolism and their outcomes. In particular, some NPs have the ability to modify glucose and lipid metabolism, and this feature is especially interesting to treat diabetes and obesity and to target cancer cells. However, the lack of specificity to reach target cells and the toxicological evaluation of nontargeted cells can potentially induce detrimental side effects, closely related to inflammation and oxidative stress. Therefore, identifying the metabolic alterations caused by NPs, independent of their application, is highly needed. To our knowledge, this increase would lead to the improvement and safer use with a reduced toxicity, increasing the number of available NPs for diagnosis and treatment of human diseases. Full article
(This article belongs to the Special Issue Micro and Nanocarriers for Biomedicine)
Show Figures

Figure 1

Back to TopTop